POST-THROMBOTIC SYNDROME
Clinical trials for POST-THROMBOTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POST-THROMBOTIC SYNDROME trials appear
Sign up with your email to follow new studies for POST-THROMBOTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cholesterol drug may stop blood clots from coming back
Disease control Recruiting nowThis study tests whether adding rosuvastatin (a common cholesterol-lowering drug) to standard blood thinners can lower the risk of another blood clot in people who recently had a deep vein thrombosis or pulmonary embolism. About 2700 adults will receive either rosuvastatin or a p…
Matched conditions: POST-THROMBOTIC SYNDROME
Phase: PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated May 17, 2026 01:32 UTC
-
New device aims to beat blood thinners for dangerous leg clots
Disease control Recruiting nowThis study tests whether a device that physically removes blood clots from the leg works better than standard blood-thinning medication alone for people with deep vein thrombosis (DVT). About 300 adults with a recent, severe clot in one leg will be randomly assigned to either the…
Matched conditions: POST-THROMBOTIC SYNDROME
Phase: NA • Sponsor: Inari Medical • Aim: Disease control
Last updated May 14, 2026 12:05 UTC